Dino Rossi Net Worth

The estimated Net Worth of Dino A Rossi is at least $29.2 Миллион dollars as of 1 March 2023. Mr. Rossi owns over 40,000 units of Krystal Biotech Inc stock worth over $16,636,934 and over the last 21 years he sold KRYS stock worth over $12,524,723. In addition, he makes $58,000 as Independent Director at Krystal Biotech Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Rossi KRYS stock SEC Form 4 insiders trading

Dino has made over 62 trades of the Krystal Biotech Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 40,000 units of KRYS stock worth $3,330,000 on 1 March 2023.

The largest trade he's ever made was exercising 73,479 units of Krystal Biotech Inc stock on 28 May 2009 worth over $484,227. On average, Dino trades about 13,931 units every 76 days since 2003. As of 1 March 2023 he still owns at least 83,691 units of Krystal Biotech Inc stock.

You can see the complete history of Mr. Rossi stock trades at the bottom of the page.

Dino Rossi biography

Dino A. Rossi serves as Independent Director of the Company. Mr. Rossi was previously employed by Balchem Corporation (Nasdaq: BCPC), where he served as Chief Executive Officer and President from October 1997 to April 2015, Chief Financial Officer from April 1996 to January 2004 and Treasurer from June 1996 to June 2003, as well as Executive Chairman from September 2015 to December 2016. He has also previously served as Vice President, Finance & Administration of Norit Americas Inc., a wholly owned subsidiary of Norit N.V. and Vice President, finance and Administration of Oakite Products Inc. Mr. Rossi is currently on the board of directors of Chroma Color Concentrates and Polytek Development Corporation. He also previously served on the boards of Elite Comfort Solutions from January 2017 to January 2019 and of Scientific Learning Corp from February 2010 to December 2011. Mr. Rossi holds a BS in Accounting from West Virginia University.

What is the salary of Dino Rossi?

As the Independent Director of Krystal Biotech Inc, the total compensation of Dino Rossi at Krystal Biotech Inc is $58,000. There are 9 executives at Krystal Biotech Inc getting paid more, with Krish S. Krishnan M.B.A., M.S. having the highest compensation of $1,008,932.

What's Dino Rossi's mailing address?

Dino's mailing address filed with the SEC is C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203.

Insiders trading at Krystal Biotech Inc

Over the last 7 years, insiders at Krystal Biotech Inc have traded over $166,816,526 worth of Krystal Biotech Inc stock and bought 536,800 units worth $5,949,380 . The most active insiders traders include Daniel Janney, Dino A Rossi и Krish S Krishnan. On average, Krystal Biotech Inc executives and independent directors trade stock every 40 days with the average trade being worth of $8,043,043. The most recent stock trade was executed by Suma Krishnan on 11 June 2024, trading 50,000 units of KRYS stock currently worth $8,788,000.

What does Krystal Biotech Inc do?

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)

Complete history of Mr. Rossi stock trades at Balchem и Krystal Biotech Inc

Krystal Biotech Inc executives and stock owners

Krystal Biotech Inc executives and other stock owners filed with the SEC include:

• Krish S. Krishnan M.B.A., M.S.,
  Founder, Chairman, Pres & CEO
• Krish S. Krishnan,
  Chairman, Pres & CEO
• Dr. Andreas C. Orth,
  Exec. VP & Chief Commercial Officer
• Suma M. Krishnan,
  Founder, COO & Director
• Krish Krishnan,
  Chairman of the Board, President, Chief Executive Officer
• Suma Krishnan,
  Founder, Chief Operating Officer, Director
• Pooja Agarwal,
  Senior Vice President, Product Development
• Kathryn A. Romano,
  Chief Accounting Officer
• R. Douglas Norby,
  Lead Independent Director
• Dino Rossi,
  Independent Director
• Daniel Janney,
  Independent Director
• Julian Gangolli.,
  Independent Director
• Ashley Robinson,
  IR Contact Officer
• Kirti Ganorkar,
  Independent Director
• J. Christopher Naftzger,
  Chief Legal Officer, Corporate Secretary
• Jennifer Chien,
  Chief Commercial Officer
• Kathryn Romano,
  Chief Accounting Officer
• David Glynn,
  Gen. Counsel, Commercial & Compliance
• Meg Dodge,
  VP of Investor Relations & Corp. Communications
• Dr. Jing L. Marantz M.B.A., M.D., Ph.D.,
  Chief Bus. Officer
• Pooja Agarwal,
  Sr. VP of Product Devel.
• Whitney Glad Ijem,
  Sr. VP of Strategy & Bus. Devel.
• Josh Suskin,
  Director of HR & Operations
• Katherine Tuminello,
  HR & Office Mang.
• John Karakkal,
  VP of North American Sales and Marketing
• Gloria Lin,
  Accounting Mang.
• Catherine Mazzacco,
  Director
• Krish S Krishnan,
  President and CEO
• Antony A Riley,
  Chief Financial Officer
• Jennifer Kayden Lee,
  Chief Commercial Officer
• Christopher Mason,
  Director
• Jing L. Marantz,
  Chief Business Officer
• Everett Rand Sutherland,
  Director